Jenny Sundqvist
Chief Executive Officer presso INDEX PHARMACEUTICALS HOLDING AB
Profilo
Jenny Sundqvist is currently the Chief Executive Officer at InDex Pharmaceuticals Holding AB.
Previously, she worked as the Chief Commercial Officer at Isofol Medical AB.
From 2017 to 2021, she held the position of Head-Oncology Portfolio at AstraZeneca PLC.
Ms. Sundqvist completed her undergraduate degree at Louisiana State University and obtained an MBA from McCombs School of Business.
Posizioni attive di Jenny Sundqvist
| Società | Posizione | Inizio |
|---|---|---|
| INDEX PHARMACEUTICALS HOLDING AB | Chief Executive Officer | 01/01/2023 |
Precedenti posizioni note di Jenny Sundqvist
| Società | Posizione | Fine |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/04/2021 |
| ISOFOL MEDICAL AB | Corporate Officer/Principal | - |
Formazione di Jenny Sundqvist
| Louisiana State University | Undergraduate Degree |
| McCombs School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| INDEX PHARMACEUTICALS HOLDING AB | Health Technology |
| ISOFOL MEDICAL AB | Health Technology |
- Borsa valori
- Insiders
- Jenny Sundqvist
